Cinclus Pharma participates in Aktiespararnas event on September 17th
On September 17th, Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of the drug candidate linaprazan glurate at Aktiespararnas event Stora Aktiedagarna.
Read more
